You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment-naïve breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 13, 2022

Breast Cancer Stage IV, Radiotherapy, Surgery Trial in France (Palbociclib, locoregional treatment)

Recruiting
  • Breast Cancer Stage IV
  • +2 more
  • Angers, France
  • +25 more
Sep 1, 2022

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022

Metastatic Breast Cancer Trial (Elacestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jul 28, 2023

Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)

Recruiting
  • Breast Cancer
  • Chidamide Plus Toripalimab Plus Paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 19, 2023

Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)

Completed
  • Cancer, Treatment-Related
  • +3 more
  • cryoablation
  • Roma, Italy
    Sapienza University of Rome
Feb 13, 2023

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

Breast Cancer Trial in Athens (Melatonin)

Completed
  • Breast Cancer
  • Melatonin
  • Athens, Greece
    Iaso Hospital
Nov 4, 2023

Young Breast Cancer Survivors Study

Recruiting
  • Breast Cancer
  • No intervention
  • Columbia, South Carolina
    University of South Carolina
Aug 9, 2023

Breast Cancer Stage I Trial (Microwave ablation)

Not yet recruiting
  • Breast Cancer Stage I
  • Microwave ablation
  • (no location specified)
May 23, 2023

Breast Cancer Female, Sexual Dysfunction Trial (Educational video series)

Not yet recruiting
  • Breast Cancer Female
  • Sexual Dysfunction
  • Educational video series
  • (no location specified)
Nov 1, 2023

Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)

Recruiting
  • Breast Cancer
  • +2 more
  • Stereotactic Ablative Radiation Therapy
  • +2 more
  • Cairo, Egypt
    National Cancer Institute
Nov 20, 2023

Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Control Arm ACSM Guidelines
  • Experimental Arm 6-12-25 repetitions per set
  • (no location specified)
Nov 6, 2023

Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))

Active, not recruiting
  • Prostate Cancer
  • Multiparametric magnetic resonance imaging (mpMRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

Dyad's Perspectives on Treatment Decision, Financial and Family

Recruiting
  • Breast Cancer
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jun 15, 2023

    Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2

    Recruiting
    • HER2-positive Breast Cancer
    • Early-stage Breast Cancer
    • pyrotinib combined with Capecitabine
    • treatment of physician's choice
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 6, 2023

    Breast Cancer, Liver Metastases Trial in Rome

    Recruiting
    • Breast Cancer
    • Liver Metastases
      • Rome, Lazio, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Oct 16, 2023

      Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

      Not yet recruiting
      • Metastatic Breast Cancer
        • Kingston, Ontario, Canada
        • +1 more
        Mar 27, 2023

        Metastatic Breast Cancer Trial in Al Madinah (Palbociclib)

        Not yet recruiting
        • Metastatic Breast Cancer
        • Al Madīnah, AL, Saudi Arabia
          Asmaa Imam Ahmed
        Oct 8, 2023

        HER2-negative Breast Cancer, Advanced Breast Cancer Trial in Guangzhou (Organoid-guided treatment, Taxane, Capecitabine)

        Not yet recruiting
        • HER2-negative Breast Cancer
        • Advanced Breast Cancer
        • Organoid-guided treatment
        • +5 more
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Oct 22, 2023

        HER2 Low Breast Carcinoma Trial (SHR-A1811 for injection)

        Not yet recruiting
        • HER2 Low Breast Carcinoma
        • SHR-A1811 for injection
        • (no location specified)
        Jun 12, 2023

        Breast Cancer Trial in San Francisco (Intake Session, Individual Sessions, Group Sessions)

        Not yet recruiting
        • Breast Cancer
        • Intake Session
        • +4 more
        • San Francisco, California
          Zuckerberg San Francisco General
        Sep 20, 2023

        Breast Cancer Trial in Tianjin (Pyrrolidine?trastuzumab?AI)

        Recruiting
        • Breast Cancer
        • Tianjin, Tianjin, China
          Tianjin Cancer Hospital
        Jun 1, 2023